BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McClure EA, Wahlquist AE, Tomko RL, Baker NL, Carpenter MJ, Bradley ED, Cato PA, Gipson CD, Gray KM. Evaluating N-acetylcysteine for early and end-of-treatment abstinence in adult cigarette smokers. Drug Alcohol Depend 2021;225:108815. [PMID: 34171822 DOI: 10.1016/j.drugalcdep.2021.108815] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
Number Citing Articles
1 Fredriksson I, Jayaram-Lindström N, Kalivas PW, Melas PA, Steensland P. N-acetylcysteine improves impulse control and attenuates relapse-like alcohol intake in long-term drinking rats. Behav Brain Res 2022;:114089. [PMID: 36063970 DOI: 10.1016/j.bbr.2022.114089] [Reference Citation Analysis]
2 Strickland JC, Stoops WW, Banks ML, Gipson CD. Logical fallacies and misinterpretations that hinder progress in translational addiction neuroscience. J Exp Anal Behav 2022. [PMID: 35362559 DOI: 10.1002/jeab.757] [Reference Citation Analysis]
3 Nall RW, Beloate LN, Meyerink ME, Penaloza T, Doolittle J, Froeliger B, Kalivas PW, Garcia-Keller C. Assessing combined effects of varenicline and N-acetylcysteine on reducing nicotine seeking in rats. Addict Biol 2022;27:e13151. [PMID: 35229943 DOI: 10.1111/adb.13151] [Reference Citation Analysis]
4 Arancini L, Mohebbi M, Berk M, Dean OM, Bortolasci CC, Spolding B, Zazula R, Dodd S. A placebo-controlled, randomised pilot trial of N-acetylcysteine or placebo for cessation of tobacco smoking. Eur Neuropsychopharmacol 2021;53:120-6. [PMID: 34757312 DOI: 10.1016/j.euroneuro.2021.10.002] [Reference Citation Analysis]